← Leaderboards
Michael Lim
Stanford University
$6,380,630
Attributed
$7,558,691
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,558,691 · 6
By mechanism
R01$5,752,096 · 3
U54$1,753,103 · 2
F32$53,492 · 1
Top collaborators
- Jung Soo Suk5 shared
Most similar at Stanford University
Same institution · by research overlap
- Carla J Shatz$21,188,317
- Yonatan Winetraub$1,944,467
- Hamed Arami$1,218,802
- Paul W. Burridge$6,528,957
- Maya Elise Kumar$2,819,165
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorImmunotherapyBrain NeoplasmsMouse ModelImmunosuppressionCellsDesignImmuneMalignant NeoplasmsImmune Checkpoint InhibitorAntigen PresentationImmune ResponseImmune SystemMediatingGlioblastomaAnti-Pd1 TherapyImmune Checkpoint BlockadeInsightMalignant Neoplasm Of BrainAnti-Tumor Immune ResponseFlow CytometryGliomaAntigen-Presenting CellsMelanoma
Grant awards (20)
Nanocage-based systemic delivery of TGFb trap for immunomodulation of brain neoplasms$417,726
R01 · FY2025 · NS
Targeting Lag-3 and PD -1 in Myeloid Cells of GBM$394,429
R01 · FY2025 · NS · contact PI
Optimizing systemic immunotherapy for personalized brain metastasis treatment$348,747
U54 · FY2025 · CA · contact PI
Nanocage-based systemic delivery of TGFb trap for immunomodulation of brain neoplasms$419,968
R01 · FY2024 · NS
Targeting Lag-3 and PD -1 in Myeloid Cells of GBM$382,582
R01 · FY2024 · NS · contact PI
Generating a Systemic Immune Response Using Localized Delivery of Chemotherapy in Brain Tumors$348,202
R01 · FY2024 · CA · contact PI
Optimizing systemic immunotherapy for personalized brain metastasis treatment$345,270
U54 · FY2024 · CA · contact PI
Nanocage-based systemic delivery of TGFβ trap for immunomodulation of brain neoplasms$505,850
R01 · FY2023 · NS
Targeting Lag-3 and PD -1 in Myeloid Cells of GBM$400,345
R01 · FY2023 · NS · contact PI
Generating a Systemic Immune Response Using Localized Delivery of Chemotherapy in Brain Tumors$359,256
R01 · FY2023 · CA · contact PI
Optimizing systemic immunotherapy for personalized brain metastasis treatment$347,313
U54 · FY2023 · CA · contact PI
Nanocage-based systemic delivery of TGFβ trap for immunomodulation of brain neoplasms$505,973
R01 · FY2022 · NS
Targeting Lag-3 and PD -1 in Myeloid Cells of GBM$402,791
R01 · FY2022 · NS · contact PI
Optimizing systemic immunotherapy for personalized brain metastasis treatment$359,712
U54 · FY2022 · CA · contact PI
Generating a Systemic Immune Response Using Localized Delivery of Chemotherapy in Brain Tumors$359,550
R01 · FY2022 · CA · contact PI
Nanocage-based systemic delivery of TGFβ trap for immunomodulation of brain neoplasms$506,606
R01 · FY2021 · NS
Optimizing systemic immunotherapy for personalized brain metastasis treatment$352,061
U54 · FY2021 · CA · contact PI
Generating a Systemic Immune Response Using Localized Delivery of Chemotherapy in Brain Tumors$374,240
R01 · FY2020 · CA · contact PI
Generating a Systemic Immune Response Using Localized Delivery of Chemotherapy in Brain Tumors$374,578
R01 · FY2019 · CA · contact PI
Targeted Gene Delivery Against Glioblastoma multiforme$53,492
F32 · FY2005 · NS